Mark J. Foley

Insider Reports History

Location
Aliso Viejo, CA
Signature
Diana Scherer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Foley:

Company Role Class Num Shares Value Price $ Report Date Ownership
GLAUKOS Corp Director Common Stock 58,389 $6,592,707 $112.91 02 Jan 2026 Direct
GLAUKOS Corp Director Stock Option (Right to Buy) 3,149 $0 $69.30 29 May 2025 Direct
Revance Therapeutics, Inc. President & CEO, Director Common Stock 0 $0 $3.65 06 Feb 2025 Direct
Revance Therapeutics, Inc. President & CEO, Director Common Stock 0 $0 $3.65 04 Feb 2025 Indirect

Insider Reports Filed by Mark J. Foley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GKOS GLAUKOS Corp 02 Jan 2026 1 $0 4 Director 07 Jan 2026, 19:10
GKOS GLAUKOS Corp 26 Feb 2025 5 -$1,326,985 4 Director 28 Feb 2025, 17:57
/report/000095017025015363-foley-mark-j-2025-02-04 Revance Therapeutics, Inc. 04 Feb 2025 5 -$4,043,645 4 President & CEO, Director 06 Feb 2025, 15:59
/report/000095017025014825-foley-mark-j-2025-02-03 Revance Therapeutics, Inc. 03 Feb 2025 1 $0 4 CEO, Director 05 Feb 2025, 19:53
GKOS GLAUKOS Corp 02 Jan 2025 3 $0 4 Director 02 Jun 2025, 16:44
/report/000147929025000004-foley-mark-j-2024-12-31 Revance Therapeutics, Inc. 31 Dec 2024 1 +$2,184 4 CEO, Director 03 Jan 2025, 16:33
/report/000147929024000104-foley-mark-j-2024-06-30 Revance Therapeutics, Inc. 30 Jun 2024 1 +$2,184 4 CEO, Director 02 Jul 2024, 17:47
GKOS GLAUKOS Corp 30 May 2024 2 $0 4 Director 03 Jun 2024, 20:56
/report/000147929024000065-foley-mark-j-2024-03-15 Revance Therapeutics, Inc. 15 Mar 2024 2 -$108,928 4 CEO, Director 19 Mar 2024, 18:43
/report/000147929024000056-foley-mark-j-2024-03-06 Revance Therapeutics, Inc. 06 Mar 2024 1 +$209,400 4 CEO, Director 08 Mar 2024, 16:33
/report/000147929024000050-foley-mark-j-2024-02-29 Revance Therapeutics, Inc. 29 Feb 2024 1 $0 4 CEO, Director 04 Mar 2024, 16:33
GKOS GLAUKOS Corp 23 Feb 2024 3 -$350,737 4 Director 26 Feb 2024, 19:01
/report/000147929024000014-foley-mark-j-2024-01-31 Revance Therapeutics, Inc. 31 Jan 2024 1 $0 4 CEO, Director 02 Feb 2024, 16:45
/report/000147929024000004-foley-mark-j-2023-12-31 Revance Therapeutics, Inc. 31 Dec 2023 1 +$1,972 4 CEO, Director 03 Jan 2024, 16:47
/report/000147929023000096-foley-mark-j-2023-08-11 Revance Therapeutics, Inc. 11 Aug 2023 2 -$908,890 4 CEO, Director 15 Aug 2023, 17:15
/report/000147929023000084-foley-mark-j-2023-08-03 Revance Therapeutics, Inc. 03 Aug 2023 1 -$593,151 4 CEO, Director 04 Aug 2023, 17:07
/report/000147929023000081-foley-mark-j-2023-06-30 Revance Therapeutics, Inc. 30 Jun 2023 2 -$639,727 4 CEO, Director 05 Jul 2023, 21:11
/report/000147929023000078-foley-mark-j-2023-06-09 Revance Therapeutics, Inc. 09 Jun 2023 1 -$960,928 4 CEO, Director 13 Jun 2023, 20:09
GKOS GLAUKOS Corp 01 Jun 2023 1 $0 4 Director 05 Jun 2023, 20:14
/report/000147929023000042-foley-mark-j-2023-03-15 Revance Therapeutics, Inc. 15 Mar 2023 1 -$163,702 4 CEO, Director 17 Mar 2023, 15:22
GKOS GLAUKOS Corp 03 Jan 2023 1 $0 4 Director 04 Jan 2023, 16:58
/report/000147929023000001-foley-mark-j-2022-12-31 Revance Therapeutics, Inc. 31 Dec 2022 1 +$7,369 4 CEO, Director 03 Jan 2023, 15:28
/report/000147929022000087-foley-mark-j-2022-10-13 Revance Therapeutics, Inc. 13 Oct 2022 1 -$1,328,920 4 CEO, Director 14 Oct 2022, 19:02
/report/000147929023000034-foley-mark-j-2022-09-22 Revance Therapeutics, Inc. 22 Sep 2022 2 -$2,223,360 4 CEO, Director 09 Mar 2023, 20:45
/report/000147929022000074-foley-mark-j-2022-06-30 Revance Therapeutics, Inc. 30 Jun 2022 1 +$11,747 4 CEO, Director 05 Jul 2022, 18:15
GKOS GLAUKOS Corp 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 19:55
/report/000120919122019723-foley-mark-j-2022-03-15 Revance Therapeutics, Inc. 15 Mar 2022 1 -$52,170 4 Chief Executive Officer, Director 17 Mar 2022, 17:54
/report/000147929023000074-foley-mark-j-2022-02-02 Revance Therapeutics, Inc. 02 Feb 2022 2 -$2,433,725 4 CEO, Director 16 May 2023, 20:29
/report/000147929022000015-foley-mark-j-2022-02-02 Revance Therapeutics, Inc. 02 Feb 2022 1 $0 4 CEO, Director 04 Feb 2022, 19:35
GKOS GLAUKOS Corp 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 19:55
/report/000147929021000169-foley-mark-j-2021-11-29 Revance Therapeutics, Inc. 29 Nov 2021 1 +$515,924 4 CEO, Director 29 Nov 2021, 20:24
/report/000147929021000158-foley-mark-j-2021-10-13 Revance Therapeutics, Inc. 13 Oct 2021 1 -$971,576 4 CEO & President, Director 15 Oct 2021, 20:00
/report/000147929021000130-foley-mark-j-2021-06-30 Revance Therapeutics, Inc. 30 Jun 2021 1 +$21,246 4 CEO & President, Director 02 Jul 2021, 19:52
GKOS GLAUKOS Corp 03 Jun 2021 1 $0 4 Director 07 Jun 2021, 19:04